Vaccinex

United States
Highland Lake, New Jersey, United States, 14620

Company profile

Vaccinex company profile

Vaccinex has developed an antibody discovery platform that enables efficient mammalian cell-based expression for expression of large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface envelope of a mammalian virus and the cell surface membrane of the infected cell. This allows them to combine the advantages of virus panning and cell sorting into one seamless selection process. This technology enables the rapid selection of 1010 antibody combinations and thus selection of high affinity leads with varied frameworks that recognize multiple epitopes. It is based in Rochester, New York.

Business identity

Contact email
[email protected]
Phone number
585-271-2700
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0+
Founded
1997-01-01, Year

Headquarters

Postal code
14620
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
13
Total equity funding
$75.9M
Last funding
Post IPO Equity / $6.2M / 2024-09-18
Last equity funding
Post IPO Equity / $6.2M
Investors
4
Lead investors
1
Founders
2
Articles
72
Exited on
2018-08-09

Founders and investors

Founders

Maurice ZaudererSteven Cobourn

Lead investors

Alzheimer's Drug Discovery Foundation

Investors

Albert FriedbergAlzheimer's Drug Discovery FoundationJacob FriebergMaurice Zauderer